SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Steliarova-Foucher F, Stiller C, Lacour B, Kaatsch P. International classification of childhood cancer. Cancer. 2005; 103: 1457-1467.
  • 2
    Barr RD. On cancer control and the adolescent. Med Pediatr Oncol. 1999; 32: 404-410.
  • 3
    Gatta G, Capocaccia R, De Angelis R, Stiller C, Coebergh JW; EUROCARE Working Group. Cancer survival in European adolescents and young adults. Eur J Cancer. 2003; 39: 2600-2610.
  • 4
    BleyerA, O'LearyM, BarrR, RiesLAG, eds. Cancer Epidemiology in Older Adolescents and Young Adults 15-29 Years of Age, Including SEER Incidence and Survival: 1975-2000. NIH Pub. No. 06-5767. Bethesda, MD: National Cancer Institute; 2006.
  • 5
    Canadian Cancer Society. Canadian Cancer Statistics 2009. Special Topic: Cancer in Adolescents and Young Adults. Toronto, Ontario, Canada: Canadian Cancer Society; 2009.
  • 6
    National Cancer Institute. Closing the Gap: Research and Care Imperatives for Adolescent and Young Adults with Cancer. Report of the Adolescent and Young Adult Oncology Progress Review Group. NIH Pub. No. 06-6067. Bethesda, MD: National Cancer Institute; 2006.
  • 7
    Stiller CA. International patterns of cancer incidence in adolescents. Cancer Treat Rev. 2007; 33: 631-645.
  • 8
    Bleyer A, Barr R. Cancer in young adults 20-39 years of age: overview. Semin Oncol. 2009; 36: 194-206.
  • 9
    Barr RD, Holowaty EJ, Birch JM. Classification schemes for tumors diagnosed in adolescents and young adults. Cancer. 2006; 106: 1425-1430.
  • 10
    Bleyer A, Barr R, Hayes-Lattin B, et al. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008; 8: 288-298.
  • 11
    Gatta G, Zigon G, Capocaccia R, et al. Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer. 2009; 45: 992-1005.
  • 12
    Bleyer A, Viny A, Barr R. Introduction. In: BleyerA, O'LearyM, BarrR, RiesLAG, eds. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000. NIH Pub. No. 06-5767. Bethesda, MD: National Cancer Institute; 2006.
  • 13
    Barr RD, Greenberg ML. Cancer surveillance and control in adolescents—similarities and contrasts between Canada and the United States. Pediatr Blood Cancer. 2006; 46: 273-277.
  • 14
    Ferrari A, Dama E, Pession A, et al. Adolescents with cancer in Italy: entry into the National Cooperative Paediatric Oncology Group AIEOP trials. Eur J Cancer. 2009; 45: 328-334.
  • 15
    Mitchell AE, Scarcella DL, Rigutto GL, et al. Cancer in adolescents and young adults: treatment outcome in Victoria. Med J Aust. 2004; 180: 59-62.
  • 16
    Bleyer A, Budd T, Montello M. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer. 2006; 107: 1645-1655.
  • 17
    Fern L, Davies S, Eden T, et al. Rates of inclusion of teenagers and young adults in England into National Cancer Research Network clinical trials: report from the National Cancer Research Institute (NCRI) Teenage and Young Adult Clinical Studies Development Group. Br J Cancer. 2008; 99: 1967-1974.
  • 18
    Nachman JB, La MK, Hunger SP, et al. Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive post-induction treatment: a report from the Children's Oncology Group. J Clin Oncol. 2009; 27: 5189-5194.
  • 19
    Bleyer A. The quid pro quo of pediatric versus adult services for older adolescent cancer patients. Pediatr Blood Cancer. 2010; 54: 238-241.
  • 20
    Peppercorn JM, Weeks JC, Cook FF, Joffe S. Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet. 2004; 363: 263-270.
  • 21
    National Cancer Research Institute. Teenage and Young Adult Clinical Studies Development Group. http://ncrndev.org.uk/index.php?option=com_content&task=view&ID=13&sitemid=270. Accessed March 18, 2010.
  • 22
    Ferrari A, Montello M, Budd T, Bleyer A. The challenges of clinical trials for adolescents and young adults with cancer. Pediatr Blood Cancer. 2008; 50: 1101-1104.
  • 23
    National Institute for Clinical Excellence. National Institute for Clinical Excellence Guidance on Cancer Services—Improving Outcomes in Children and Young People with Cancer. London, United Kingdom: National Institute for Clinical Excellence; 2005.
  • 24
    Mertens AC, Yasui Y, Neglia JP, et al. Late mortality experience in 5-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol. 2001; 19: 3163-3172.
  • 25
    Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006; 355: 1572-1582.
  • 26
    WeinerSL, SimoneJV, HewittM, eds. Childhood Cancer Survivorship: Improving Care and Quality of Life. Institute of Medicine, National Research Council. Washington, DC: National Academies Press; 2003.
  • 27
    HewittM, GreenfieldS, StovallE, eds. From Cancer Patient to Cancer Survivor. Lost in Transition. Institute of Medicine, National Research Council. Washington, DC: National Academies Press; 2005.
  • 28
    Barr RD, Sala A. Quality-adjusted survival: a rigorous assessment of cure after cancer during childhood and adolescence. Pediatr Blood Cancer. 2005; 44: 201-204.
  • 29
    Grant J, Cranston A, Horsman J, et al. Health status and health-related quality of life in adolescent survivors of cancer in childhood. J Adolesc Health. 2006; 38: 540-510.
  • 30
    Zebrack BJ, Donohue JE, Gurney JG, Chesler MA, Bhatia S, Landier W. Psychometric evaluation of the Impact of Cancer (IOC-CS) scale for young adult survivors of childhood cancer. Qual Life Res. 2010; 19: 207-218.
  • 31
    Barr RD. Feeny D, Furlong W. Economic evaluation of treatments for cancer in childhood. Eur J Cancer. 2004; 40: 1335-1345.
  • 32
    Bridges JFP, Onukwugha E, Mullins CD. Healthcare rationing by proxy. Cost-effectiveness analysis and the misuse of the $50,000 threshold in the United States. Pharmacoeconomics. 2010; 28: 175-154.
  • 33
    The Canadian Cancer Research Alliances. Cancer Research Investment in Canada, 2007. Toronto, Ontario, Canada: Canadian Partnership Against Cancer; 2009.
  • 34
    Reynolds KD, Blaum JM, Jester PM, Weiss H, Soong S-J, Diclimente RJ. Predictors of sun exposure in adolescents in a south eastern US population. J Adolesc Health. 1996; 6: 409-415.
  • 35
    Robinson JK, Rademaker AW, Sylvester JA, Cook B. Summer sun exposure: knowledge, attitudes and behaviors of Midwest adolescents. Prev Med. 1997; 26: 364-372.
  • 36
    Lower T, Girgis A, Samson-Fisher R. The prevalence and predictors of solar protection use among adolescents. Prev Med. 1998; 27: 391-399.
  • 37
    Jubelirer SJ, Blanton MF, Blanton PD, et al. Assessment of knowledge, attitudes and behaviors relative to cervical cancer and the Pap smear among adolescent girls in West Virginia. J Cancer Educ. 1996; 11: 230-232.
  • 38
    Mangan SA, Legano LA, Rosen CM, et al. Increased prevalence of abnormal Papanicolaou smears in urban adolescents. Arch Pediatr Adolesc Med. 1997; 151: 481-484.
  • 39
    Lazcano-Ponce EC, Najera-Aguilar P, Buiatti E, et al. The cervical cancer screening program in Mexico: problems with access and coverage. Cancer Causes Control. 1997; 8: 698-704.
  • 40
    Tomar SL, Winn DM, Swango PA, Giovino GA, Kleinman DV. Oral mucosal smokeless tobacco lesions among adolescents in the United States. J Dent Res. 1997; 76: 1277-1286.
  • 41
    Schinke SP, Singer B, Cole K, Contento IR. Reducing cancer risk among Native American adolescents. Prev Med. 1996; 25: 146-155.
  • 42
    Barg FK, Lowe JI. A culturally appropriate cancer education program for African-American adolescents in an urban middle school. J School Health. 1996; 66: 50-54.
  • 43
    Hollen PJ, Hobbie WL. Decision making and risk behaviors of cancer-surviving adolescents and their peers. J Pediatr Oncol Nurs. 1996; 13: 121-134.
  • 44
    Hudson MM, Tyc VL, Srivastava DK, et al. Multi-component behavioral intervention to promote health protective behaviors in childhood cancer survivors: the Protect Study. Med Pediatr Oncol. 2002; 39: 2-11.
  • 45
    LIVESTRONG web site. http://www.livestrong.org/summit. Accessed March 8, 2010.
  • 46
    Barr RD, Eden T. International Working Group on Adolescent/Teeneage and Young Adult Oncology (Supplement: SIOP Symposium on Adolescent and Young Adult Oncology). Pediatr Blood Cancer. 2008; 50( suppl 5): 1089-1119.
  • 47
    Albritton K, Barr R, Bleyer A. The adolescence of young adult oncology. Semin Oncol. 2009; 36: 478-488.
  • 48
    Schwartz CL. Health status of childhood cancer survivors. Cure is more than eradication of cancer. JAMA. 2003; 290: 1641-1643.